top of page

Takeda and M2Gen team up with ORIEN to speed drug development

Takeda and M2Gen are to collaborate with the Oncology Research Information Exchange Network (ORIEN) to speed the development of cancer therapeutics through health informatics.

Under the agreement, Takeda and M2Gen will help build the ORIEN Avatar Research Programme based on the Total Cancer Care Protocol, a prospective observational study enrolling patients with various cancers, and access information generated under this programme.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page